Developments with BCMA-Directed Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: Clinical Updates and Future Directions for Therapy
This interactive program will provide clinicians who care for people with multiple myeloma with important updates about current and future management of the diseases. It includes two animations and case study discussions.
RELEASED DATE: January 30, 2024
EXPIRATION DATE: January 30, 2025